We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
Find out if your business is eligible for tailored in-market support as part of the Export Support Service from the Department for Business and Trade.
Submissions related to human medicines need to be submitted directly to the MHRA.
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
A toolkit for Homes England partners containing useful Help to Build marketing information.
How the MHRA processes variations to Marketing Authorisations (MAs)
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
What you need to know about and do to comply with the law and keep consumers safe.
Benefit from your design by licensing, mortgaging, selling, changing ownership and exploit by marketing.
The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.
This section provides guidance for communications network providers on legislation, regulation, working with local authorities and with property developers.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
How to apply for marketing authorisation via this new procedure.
How the MHRA assesses Marketing Authorisation Applications (MAA) for medicines referred under Article 29.
Benefit from your trade mark by licensing, mortgaging, selling, transferring ownership, merging and exploit by marketing.
How to get help researching export markets and sign up for seminars on exporting.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).